Intestinal enzyme responsive zein-based nano-particles with high mucus permeation-cell absorption and preparation method of intestinal enzyme responsive zein-based nano-particles

By preparing charge-turned zein nanoparticles, the intestinal alkaline phosphatase response mechanism is used to solve the problems of mucus permeation and cell absorption of nanoparticles in the intestine, achieving efficient intestinal delivery and material safety High, good biocompatibility.

CN119014529APending Publication Date: 2024-11-26TIANJIN UNIV OF SCI & TECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410937883.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

There is a contradiction between mucus permeability and epithelial cell uptake when existing oral nanoparticles overcome the intestinal barrier, making it difficult to effectively penetrate the mucus and epithelial layer, resulting in low bioavailability.

Method used

Using zein, chitosan and sodium polyphosphate as raw materials, charge-turned nanoparticles responded by intestinal alkaline phosphatase-responsive use of alkaline phosphatase in the intestinal environment The enzyme performs charge flips, achieving mucus penetration and cellular absorption.

Benefits of technology

The prepared nanoparticles have high mucus permeability and cell absorption capacity, and can penetrate the mucus layer and epithelial layer at the same time, improve bioavailability, and use food-borne materials, which have good safety and biocompatibility.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119014529A_ABST
    Figure CN119014529A_ABST
Patent Text Reader

Abstract

The invention discloses intestinal enzyme responsive zein-based nanoparticles with high mucus permeation-cell absorption and a preparation method of the intestinal enzyme responsive zein-based nanoparticles. The preparation method comprises the following steps: preparing an embedding material / zein solution, a chitosan solution and a sodium polyphosphate solution; dropwise adding the embedded material / zein solution into the chitosan solution, and stirring to form an embedded material-loaded zein-chitosan nanoparticle solution; adding the zein-chitosan nanoparticle solution loaded with the embedding material into a sodium polyphosphate solution, and stirring to form a zein-chitosan-sodium polyphosphate nanoparticle solution of the embedding material; and removing redundant ethanol in the zein-chitosan-sodium polyphosphate nanoparticle solution, and adjusting the pH value to obtain the high mucus permeation-cell absorption intestinal enzyme responsive zein-based nanoparticles. The mucous layer barrier and the epithelial layer barrier can be coped with at the same time, and high mucous permeation and cellular uptake are achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of functional nanomaterial preparation, and in particular to an intestinal enzyme-responsive zein-based nanoparticle with high mucus penetration and cell absorption and a preparation method thereof. Background Art

[0002] Oral nanoparticles play an important role in nutrient delivery, especially for people who need to take medicines or nutritional supplements for a long time. In recent years, there has been an endless stream of research on oral nanoparticles based on peptides or proteins, because oral nanoparticles based on peptides or proteins often have higher physical compatibility. In addition, some peptides or proteins used to synthesize nanoparticles have certain nutritional activities themselves, which can play a certain advantage in preventing and treating diseases. However, oral peptide / protein nanoparticles on the market have disadvantages such as poor solubility, poor stability, and environmental sensitivity, and are difficult to cope with the intestinal barrier of the human body. The intestinal barrier includes mucus barrier and epithelial barrier, and nanoparticles need to penetrate these two barriers step by step to exert their effective activity. Therefore, in order to improve the bioavailability of active substances, designing and constructing nanonutrient delivery carriers that penetrate mucus and are efficiently coupled to be taken up by epithelial cells, and exploring the transport mechanism of carrier materials across diffusion and uptake barriers in vivo and in vitro have become important topics in nanonutrient delivery systems.

[0003] The mucus barrier refers to a viscoelastic network hydrogel composed of mucin, liposomes, electrolytes and water, among which mucin with high negative charge is the main component of the mucus layer. The mucus layer is distributed throughout the surface of the small intestine and is the first line of defense for intestinal immunity. When nanoparticles are captured by the mucus layer, they will be excreted from the body as the body metabolizes. Mucin fibers will cross-link with nanoparticles through van der Waals forces, hydrophobic interactions, hydrogen bonds and electrostatic interactions, which prevents nanoparticles from reaching the epithelial layer. Studies have shown that small-sized (<100nm) nanoparticles can avoid the steric hindrance caused by the mucin network structure, and nanoparticles with virus-like neutral surfaces and hydrophilic polymer coatings can avoid electrostatic and hydrophobic interactions with mucin. However, after overcoming the mucus layer barrier, nanoparticles will face the epithelial layer barrier. Epithelial cells are the most abundant cells on the intestinal surface and are also the main absorption site for the small intestine to absorb active ingredients. Nanoparticles can cross the epithelial barrier through transcellular and paracellular pathways, but this requires the nanoparticles to have a positively charged and hydrophobic outer surface. It can be seen that the two barriers have completely opposite requirements on the properties of the nanoparticle surface. Therefore, the contradictory relationship between the mucus permeability and epithelial uptake of nanodelivery vehicles has become a major challenge in improving the delivery efficiency of mucus-permeable and intestinal-absorbable nanoparticles.

[0004] Previous studies usually use zwitterions containing both anionic and cationic groups, such as polyethylene glycol, polyvinyl alcohol, and polydopamine, as surface modification materials to construct nanocarriers. Such delivery bodies have excellent mucus permeability and cell uptake. However, considering that zwitterions are not natural raw materials, this paper uses food-derived zein as a raw material to construct nanocarriers that overcome the mucus and epithelial barrier. Taking alkaline phosphatase expressed in the intestinal environment as the initiator, combined with the characteristics of intestinal alkaline phosphatase that can hydrolyze anionic phosphate groups in a directional manner, sodium polyphosphate was selected as a modifier of zein to achieve dephosphorylation of nanoparticles in the intestinal environment. Considering the cell uptake characteristics, chitosan, a positively charged and hydrophobic substance, was selected as the inner layer modifier, and sodium polyphosphate was selected as the outermost layer modifier to achieve the reversal of the charge and hydrophilicity of the nanoparticles after sodium polyphosphate was cleaved by intestinal alkaline phosphatase. Summary of the invention

[0005] The purpose of the present invention is to provide a method for preparing intestinal enzyme-responsive zein-based nanoparticles with high mucus penetration and cell absorption in response to the technical defects in the prior art. The method is guided by mucus penetration and cell uptake efficiency, uses zein, chitosan and sodium polyphosphate as raw materials, and prepares a charge-flipping zein-based nanoparticle based on intestinal alkaline phosphatase response through anti-solvent co-precipitation and electrostatic adsorption.

[0006] Another aspect of the present invention is to provide an intestinal enzyme-responsive zein-based nanoparticle with high mucus penetration and cell absorption obtained by the preparation method, which has high safety, good biocompatibility and can be used in food systems.

[0007] The technical solution adopted to achieve the purpose of the present invention is:

[0008] A method for preparing intestinal enzyme-responsive zein-based nanoparticles with high mucus permeability and cell absorption, comprising the following steps:

[0009] Step 1, weighing zein powder and an embedding material, dissolving them in an ethanol-water solution respectively, then mixing and stirring them thoroughly to dissolve, and centrifuging to obtain a supernatant to obtain an embedding material / zein solution;

[0010] Weigh chitosan and dissolve it in acetic acid-water solution, stir thoroughly to dissolve, and obtain a chitosan solution;

[0011] Weigh sodium polyphosphate powder and dissolve it in distilled water, stir it thoroughly to dissolve it, and obtain a sodium polyphosphate solution;

[0012] Step 2, under stirring conditions, dropwise adding the embedded material / zein solution obtained in step 1 into the chitosan solution, and stirring to form an embedded material-carrying zein-chitosan nanoparticle solution;

[0013] Step 3, under stirring conditions, adding the zein-chitosan nanoparticle solution loaded with the embedded material obtained in step 2 to an equal volume of sodium polyphosphate solution, and stirring to form a zein-chitosan-sodium polyphosphate nanoparticle solution loaded with the embedded material;

[0014] Step 4, placing the zein-chitosan-sodium polyphosphate nanoparticle solution of the embedding material obtained in step 3 in a negative pressure rotary evaporator to remove excess ethanol, adjusting the pH value, and obtaining intestinal enzyme-responsive zein-based nanoparticles with high mucus penetration and cell absorption.

[0015] In the above technical solution, the embedded material is curcumin.

[0016] In the above technical solution, in step 1, the mass ratio of zein powder to embedding material is 9:1 to 11:1.

[0017] In the above technical solution, in step 1, the centrifugal speed is 10000-12000 rpm, the centrifugal temperature is 4-8°C, and the centrifugal time is 20-30 min.

[0018] In the above technical solution, in step 1, the molecular weight of chitosan is 400-600 kDa, and chitosan is dissolved in an acetic acid aqueous solution at 80-90° C. in a water bath.

[0019] In the above technical solution, in step 2, the mass ratio of chitosan to zein powder is 5.5:1 to 6.5:1.

[0020] In the above technical solution, magnetic stirring is used in step 1, step 2 and step 3, the stirring rate is 600-800 rpm, and the stirring time of each step is 45-60 min.

[0021] In the above technical solution, the dropping speed in step 2 is 2 to 4 drops / second.

[0022] In the above technical solution, in step 3, the mass ratio of chitosan to sodium polyphosphate is 1:0.2 to 1:4.0.

[0023] In the above technical solution, in step 3, the concentration of zein is 0.5-1.0 mg / mL, the concentration of chitosan is 0.1-0.2 mg / mL, and the concentration of sodium polyphosphate is 0.02-0.3 mg / mL.

[0024] In the above technical solution, in step 4, the temperature of the negative pressure rotary evaporator is 40 to 50°C, and the pressure is -0.1 to -0.2 MPa; and the pH value is adjusted to 3.5 to 4.0.

[0025] Another aspect of the present invention also includes intestinal enzyme-responsive zein-based nanoparticles with high mucus penetration and cell absorption obtained by the preparation method.

[0026] Compared with the prior art, the present invention has the following beneficial effects:

[0027] 1. The raw materials used in the present invention are all food-derived materials, and have biocompatibility and biosafety;

[0028] 2. The charge reversal nanoparticles prepared by the present invention are nanoparticles based on intestinal alkaline phosphatase response, and the charge reversal response mechanism is very simple and convenient;

[0029] 3. The zein nanoparticles prepared by the present invention can simultaneously cope with the mucus layer barrier and the epithelial layer barrier, achieving high mucus penetration and cellular uptake. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 (A) is a microscopic morphology of the intestinal enzyme-responsive zein-based nanoparticles with high mucus penetration-cell absorption in Examples 1, 2, and 3, and (B) is a Fourier infrared spectrum;

[0031] Figure 2 It is a charge reversal verification diagram of the intestinal enzyme responsive zein-based nanoparticles with high mucus penetration and cell absorption in Examples 1, 2, and 3;

[0032] Figure 3 is the in vitro simulated mucus layer permeability of the intestinal enzyme responsive zein-based nanoparticles with high mucus permeability-cell absorption in Examples 1, 2, and 3;

[0033] Figure 4 This is the in vitro Caco-2 cell uptake of intestinal enzyme-responsive zein-based nanoparticles with high mucus permeability and cellular absorption in Example 1, 2, and 3, wherein (A) is the cellular uptake observed using CLSM, and (B) is the cellular uptake characterized by the intracellular mean fluorescence intensity. DETAILED DESCRIPTION

[0034] The present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0035] Example 1

[0036] A highly mucus permeable and cell-absorbable intestinal enzyme-responsive zein-based nanoparticle is prepared by the following method:

[0037] Step 1, at room temperature and pressure, weigh 1200 mg of zein and 120 mg of curcumin, dissolve them in 50 mL of 70% (v / v) ethanol-water solution, mix the two solutions with a magnetic stirrer, stir at 600 rpm for 60 min until the solution is uniform and transparent, then centrifuge at 10000 rpm for 20 min, remove the insoluble part to obtain a curcumin / zein solution with a protein concentration of 12 mg / mL;

[0038] At room temperature and pressure, weigh 20 mg of chitosan powder and dissolve it in 90 mL of 0.1% (v / v) acetic acid-water solution; stir it with a magnetic stirrer for 60 min under heating conditions until the solution is uniform and transparent, thereby preparing a chitosan solution;

[0039] At room temperature and pressure, weigh 4 mg of sodium polyphosphate powder, dissolve it in 100 mL of distilled water, and stir it with a magnetic stirrer for 60 min until the solution is uniform and transparent to prepare a 0.04 mg / mL sodium polyphosphate solution;

[0040] Step 2: under magnetic stirring, using a syringe, dropwise add the curcumin / zein solution obtained in step 1 to the chitosan solution, so that the final zein concentration is 1.2 mg / mL and the final chitosan concentration is 0.2 mg / mL. Stir for 45 minutes to form a curcumin / zein-chitosan nanoparticle solution;

[0041] Step 3, under magnetic stirring, the sodium polyphosphate solution obtained in step 1 is quickly added to the curcumin / zein-chitosan nanoparticle solution obtained in step 2, so that the final zein concentration is 0.6 mg / mL, the final chitosan concentration is 0.1 mg / mL, and the final sodium polyphosphate concentration is 0.02 mg / mL. Stir for 45 minutes to form a curcumin / zein-chitosan-sodium polyphosphate nanoparticle solution;

[0042] Step 4, the curcumin / zein-chitosan-sodium polyphosphate nanoparticle solution prepared in step 3 is removed from excess ethanol in a high-pressure rotary evaporator (45° C., −0.1 MPa), the solution is adjusted to pH 3.8±0.1, and the volume before rotary evaporation is replenished with ultrapure water (in order to ensure that the protein concentration of each example sample is the same), to obtain intestinal enzyme-responsive zein-based nanoparticles with high mucus penetration-cellular absorption.

[0043] Example 2

[0044] A highly mucus permeable and cell-absorbable intestinal enzyme-responsive zein-based nanoparticle is prepared by the following method:

[0045] Step 1, at room temperature and pressure, weigh 1200 mg of zein and 120 mg of curcumin, dissolve them in 50 mL of 70% (v / v) ethanol-water solution, mix the two solutions with a magnetic stirrer, stir at 600 rpm for 60 min until the solution is uniform and transparent, then centrifuge at 10000 rpm for 20 min, remove the insoluble part to obtain a curcumin / zein solution with a protein concentration of 12 mg / mL;

[0046] At room temperature and pressure, weigh 20 mg of chitosan powder and dissolve it in 90 mL of 0.1% (v / v) acetic acid-water solution; stir it with a magnetic stirrer for 60 min under heating conditions until the solution is uniform and transparent, and prepare chitosan solutions of different concentrations;

[0047] At room temperature and pressure, weigh 16 mg of sodium polyphosphate powder, dissolve it in 100 mL of distilled water, and stir it with a magnetic stirrer for 60 min until the solution is uniform and transparent to prepare a 0.16 mg / mL sodium polyphosphate solution;

[0048] Step 2: under magnetic stirring, using a syringe, dropwise add the curcumin / zein solution obtained in step 1 to the chitosan solution, so that the final zein concentration is 1.2 mg / mL and the final chitosan concentration is 0.2 mg / mL. Stir for 45 minutes to form a curcumin / zein-chitosan nanoparticle solution;

[0049] Step 3, under magnetic stirring, the sodium polyphosphate solution obtained in step 1 is quickly added to the curcumin / zein-chitosan nanoparticle solution obtained in step 2, so that the zein concentration is 0.6 mg / mL, the final chitosan concentration is 0.1 mg / mL, and the final sodium polyphosphate concentration is 0.08 mg / mL. Stir for 45 minutes to form a curcumin-loaded zein-chitosan-sodium polyphosphate nanoparticle solution;

[0050] Step 4: Remove excess ethanol from the curcumin-loaded zein-chitosan-sodium polyphosphate nanoparticle solution obtained in step 3 in a high-pressure rotary evaporator (45° C., −0.1 MPa), adjust the solution to a pH of 3.8±0.1, and fill the volume before rotary evaporation with ultrapure water.

[0051] Example 3

[0052] A highly mucus permeable and cell-absorbable intestinal enzyme-responsive zein-based nanoparticle is prepared by the following method:

[0053] Step 1, at room temperature and pressure, weigh 1200 mg of zein and 120 mg of curcumin, dissolve them in 50 mL of 70% (v / v) ethanol-water solution, mix the two solutions with a magnetic stirrer, stir at 600 rpm for 60 min until the solution is uniform and transparent, then centrifuge at 10000 rpm for 20 min, remove the insoluble part to obtain a curcumin / zein solution with a protein concentration of 12 mg / mL;

[0054] At room temperature and pressure, weigh 20 mg of chitosan powder and dissolve it in 90 mL of 0.1% (v / v) acetic acid-water solution; stir it with a magnetic stirrer for 60 min under heating conditions until the solution is uniform and transparent, and prepare chitosan solutions of different concentrations;

[0055] At room temperature and pressure, weigh 60 mg of sodium polyphosphate powder, dissolve it in 100 mL of distilled water, and stir it with a magnetic stirrer for 60 min until the solution is uniform and transparent to prepare a 0.6 mg / mL sodium polyphosphate solution;

[0056] Step 2: under magnetic stirring, using a syringe, dropwise add the curcumin / zein solution obtained in step 1 to the chitosan solution, so that the final zein concentration is 1.2 mg / mL and the final chitosan concentration is 0.2 mg / mL. Stir for 45 minutes to form a curcumin / zein-chitosan nanoparticle solution;

[0057] Step 3, under magnetic stirring, quickly add the sodium polyphosphate solution obtained in step 1 to the curcumin / zein-chitosan nanoparticle solution obtained in step 2, so that the final zein concentration is 0.6 mg / mL, the final chitosan concentration is 0.1 mg / mL, and the final sodium polyphosphate concentration is 0.3 mg / mL. Stir for 45 minutes to form a curcumin / zein-chitosan-sodium polyphosphate nanoparticle solution;

[0058] Step 4: remove excess ethanol from the curcumin / zein-chitosan-sodium polyphosphate nanoparticle solution prepared in step 3 in a high pressure rotary evaporator (45° C., −0.1 MPa), adjust the solution to pH 3.8±0.1, and fill the volume before rotary evaporation with ultrapure water.

[0059] Comparative Example 1

[0060] A zein nanoparticle solution is prepared by the following steps:

[0061] Step 1, at room temperature and pressure, weigh 1200 mg of zein and 120 mg of curcumin, dissolve them in 50 mL of 70% (v / v) ethanol-water solution, mix the two solutions with a magnetic stirrer, stir at 600 rpm for 60 min until the solution is uniform and transparent, then centrifuge at 10000 rpm for 20 min, remove the insoluble part to obtain a curcumin / zein solution with a protein concentration of 12 mg / mL;

[0062] Step 2, under magnetic stirring, using a syringe to dropwise add the curcumin / zein solution obtained in step 1 into ultrapure water to a final protein concentration of 1.2 mg / mL. Stir for 45 minutes to form a curcumin / zein nanoparticle solution;

[0063] Step 3, removing excess ethanol from the curcumin / zein nanoparticle solution prepared in step 2 in a high pressure rotary evaporator (45° C., −0.1 MPa), adjusting the solution to pH 3.8±0.1, and filling the original volume with ultrapure water.

[0064] Comparative Example 2

[0065] A zein nanoparticle solution is prepared by the following steps:

[0066] Step 1, at room temperature and pressure, weigh 1200 mg of zein and 120 mg of curcumin, dissolve them in 50 mL of 70% (v / v) ethanol-water solution, mix the two solutions with a magnetic stirrer, stir at 600 rpm for 60 min until the solution is uniform and transparent, then centrifuge at 10000 rpm for 20 min, remove the insoluble part to obtain a curcumin / zein solution with a protein concentration of 12 mg / mL;

[0067] At room temperature and pressure, weigh 20 mg of chitosan powder and dissolve it in 90 mL of 0.1% (v / v) acetic acid-water solution; stir it with a magnetic stirrer for 60 min under heating conditions until the solution is uniform and transparent, and prepare chitosan solutions of different concentrations;

[0068] Step 2: under magnetic stirring, using a syringe, dropwise add the curcumin / zein solution obtained in step 1 to the chitosan solution, so that the final protein concentration is 1.2 mg / mL and the final chitosan concentration is 0.2 mg / mL. Stir for 45 minutes to form a curcumin / zein-chitosan nanoparticle solution;

[0069] Step 3, removing excess ethanol from the curcumin / zein-chitosan nanoparticle solution prepared in step 2 in a high pressure rotary evaporator (45° C., −0.1 MPa), adjusting the solution to pH 3.8±0.1, and filling the original volume with ultrapure water.

[0070] The zein nanoparticle solutions prepared in Examples 1-3 and Comparative Examples 1-2 were analyzed as follows:

[0071] Determination of average particle size, dispersion index, zeta potential, encapsulation efficiency, micromorphology and infrared spectrum: After diluting the nanoparticle solution to an appropriate concentration, the particle size distribution, polydispersity index and zeta potential of the sample were determined using a nano-laser particle size analyzer and a zeta potential analyzer. Each sample was measured 6 times in parallel and the average value was taken. According to the different solubility of curcumin and zein in ethanol aqueous solution of different concentrations, the encapsulation efficiency of the nanoparticle sample was determined by freeze-drying and re-dissolution method. The micromorphology of the nanoparticles was observed using a field emission electron microscope. The infrared spectra of each substance in the sample were analyzed using a Fourier transform infrared spectrometer to determine the changes in the functional groups on the surface of the sample.

[0072] The mucus penetration ability of nanoparticles was verified using a 24-well Transwell system (PC membrane, membrane surface area 33.6 mm 2 The mucus permeability of nanoparticles was studied in a transwell (1 μm pore size) experiment. First, a certain amount of mucin powder was dissolved in ultrapure water, and the sample was fully dissolved under a magnetic stirrer and the final concentration was 20 mg / mL. Subsequently, 50 μL of mucus solution was evenly applied to the PC membrane of the upper chamber of the Transwell, and 550 μL of PBS solution was added to the lower chamber of the Transwell. After that, 200 μL of the Cur-containing nanoparticle sample was carefully added to the upper layer of mucus and incubated in the dark at 37 ° C and 100 rpm for 4 hours. After the end, the content of nanoparticles in the lower chamber was measured.

[0073] Verification of the cellular uptake of nanoparticles: The uptake of nanoparticles by Caco-2 cells was observed using CLSM. When the confluence of Caco-2 cells reached 80%, the original culture medium was discarded, and the cells were washed and the culture medium containing nanoparticles was added. After 6 hours, the original culture medium was discarded, and the cell layer was washed and 4% paraformaldehyde solution was added under light-proof conditions. After 15 minutes, the cells were washed and the cell nuclei were stained with DAPI solution, and observed under CLSM water microscope after 15 minutes. In order to quantify the cellular uptake of nanoparticles, Caco-2 cells were inoculated at a certain density in six-well plates and incubated. When the cells grew to 80%, the original culture medium was removed, and the cells were washed and the culture medium containing nanoparticles was added for incubation. After 6 hours, the cells were washed with pre-cooled PBS, and RIPA solution (200μL / well) was added to lyse the cells under ice bath conditions. After 30 minutes, the lysed cell suspension was collected and centrifuged (20000rpm, 4℃, 20min). Take the supernatant and add a certain amount of DMSO, and measure the fluorescence intensity of curcumin in the solution to determine the amount of nanoparticles in the cells.

[0074] Result analysis:

[0075] 1. Particle size, PDI index, zeta potential and encapsulation efficiency of nanoparticles:

[0076] As shown in Table 1, the average particle sizes of Examples 1-3 are 101.98±4.23nm, 3.92±0.37μm and 103.83±2.53nm, respectively. The particle size of Example 2 shows a sharp increase. This is because the system is electrically neutral at this time, and the electrostatic repulsion between the particles is weak, so it is difficult for the system to maintain a stable state, and the nanoparticles are significantly aggregated. However, the particle size of individual particles in Example 2 still needs further study. The average particle size of Examples 1 and 3 is significantly lower than that of Comparative Example 1. The PDI of Examples 1-3 is distributed between 0.015-0.005, which shows that its uniformity is good. The encapsulation efficiency of Examples 1-3 is between 80.74% and 82.66%, which is not significantly different from the encapsulation efficiency of Comparative Example 1 (81.74%).

[0077] Table 1 Particle size, PDI, zeta potential and encapsulation efficiency of different nanoparticles.

[0078]

[0079]

[0080] 2. Microscopic morphology of nanoparticles:

[0081] like Figure 1 As shown in (A), the shape of comparative example 1 is irregular and the uniformity is poor. After modification with chitosan, the shape of some particles is more regular and presents a uniform sphere. The morphology of Examples 1-3 presents a more uniform and smooth form. This is because sodium polyphosphate has a surface active effect, which can improve the surface structure of the particles after addition, thereby improving the uniformity and stability of the nanoparticles. The image of Example 2 observed obvious aggregation between the particles, which is consistent with the dynamic light scattering results. It is worth noting that although the particles in the figure are in an aggregated form, the diameter of a single particle is still around 100nm.

[0082] 2. Infrared spectrum of nanoparticles:

[0083] like Figure 1 As shown in (B), in Examples 1-3, it is located at 3415.60 cm -1 The characteristic peak at 3420 cm -1 This is attributed to the hydrogen bonding between zein and chitosan. After combining with sodium polyphosphate, this peak continues to red-shift to 3432 cm -1 Chitosan is at 1420.56 cm due to the deprotonation of the amino group.-1 A characteristic peak appears. The characteristic peak representing the phosphate group in sodium polyphosphate is located at 1089.77 cm -1 In the infrared spectrum curves of Examples 1-3, it can be observed that the two peaks are shifted to 1412 cm -1 Nearby and 1020cm -1 This change further confirms the electrostatic effect between chitosan and sodium polyphosphate.

[0084] 3. In vitro mucus permeability determination of nanoparticles:

[0085] like Figure 2 As shown, the isoconditional Transwell model without coating the mucus layer and only adding nanoparticles is recorded as 100% diffusion. After 4h, the permeability coefficient of Example 2 (89.47±1.68%) is the highest, followed by Example 3 (72.28±2.11%) and Example 1 (57.11±3.5%), and finally Comparative Example 1 (48.51±0.63%) and Comparative Example 2 (43.05±1.62%). This is because Comparative Example 1, which has not been surface modified, has surface hydrophobicity and positive charge, so the mucus permeability is poor. After modification with chitosan, the mucus permeability of the hydrophobic and positively charged Comparative Example 2 cannot be improved. The permeability results of Examples 1-3 prove that the sodium polyphosphate coating gives the nanoparticles a hydrophilic and negatively charged outer surface, thereby improving the mucus permeability.

[0086] 4. Verification of the charge reversal capability of nanoparticles:

[0087] like Figure 3 As shown, the charge reversal of Examples 1-3 was evaluated using intestinal alkaline phosphatase isolated from the pig intestine. The zeta potential charge of Examples 1-3 was measured at 0, 15, 30, 60, 90 and 120 min of incubation with IAP enzyme. Within 2 hours, the zeta potential of the electronegative Example 3 increased from -32.44±1.33mV to 6.11±2.20mV, the zeta potential of the electrically neutral Example 2 increased from -0.334±3.13mV to 11.92±0.97mV, and the zeta potential of the electrically positive Example 1 increased from 33.99±1.90mV to 41.91±2.73mV. The above results show that Examples 1-3 can hydrolyze the outer layer of sodium polyphosphate through intestinal alkaline phosphatase response, thereby changing the surface charge of the particles, so that the electrically neutral or electronegative particles are electrically positive when they reach the intestinal epithelium.

[0088] 5. Determination of in vitro cellular uptake rate of nanoparticles:

[0089] Uptake of Caco-2 cells and nanoparticle samples without IAP enzyme (A) and with IAP enzyme (B) Figure 4 As shown. Among them, after comparative example 1 was incubated with cells for 6h, only a weak fluorescence peak was shown in the CLSM image. In contrast, a large amount of yellow fluorescence corresponding to curcumin was observed in the nucleus and cytoplasm of Caco-2 cells treated with comparative example 2, proving that chitosan modification helps nanoparticles enter cells. Studies have shown that highly negatively charged heparin sulfate proteoglycans on the cell surface play an important role in cellular uptake, so cationic polymers can enhance cellular uptake through electrostatic interactions. When the nanoparticles were treated with intestinal alkaline phosphatase, the cell uptake of Examples 1-3 changed significantly, and enhanced yellow fluorescence could be observed in the cells. The uptake of the nanocarriers in the cell layer after charge reversal can be increased to 3.7 times the previous amount. This can also prove that the change in zeta potential of Examples 1-3 under enzymatic activation of intestinal alkaline phosphatase can affect the internalization of nanoparticles by Caco-2 cells.

[0090] The above is only a preferred embodiment of the present invention. It should be pointed out that, for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for preparing intestinal enzyme-responsive zein-based nanoparticles with high mucus penetration and cell absorption, characterized in that: The following steps are involved: Step 1, weighing zein powder and an embedding material, dissolving them in an ethanol-water solution respectively, then mixing and stirring them thoroughly to dissolve, and centrifuging to obtain a supernatant to obtain an embedding material / zein solution; Weigh chitosan and dissolve it in acetic acid-water solution, stir thoroughly to dissolve, and obtain a chitosan solution; Weigh sodium polyphosphate powder and dissolve it in distilled water, stir it thoroughly to dissolve it, and obtain a sodium polyphosphate solution; Step 2, under stirring conditions, dropwise adding the embedded material / zein solution obtained in step 1 into the chitosan solution, and stirring to form an embedded material-carrying zein-chitosan nanoparticle solution; Step 3, under stirring conditions, adding the zein-chitosan nanoparticle solution loaded with the embedded material obtained in step 2 to an equal volume of sodium polyphosphate solution, and stirring to form a zein-chitosan-sodium polyphosphate nanoparticle solution loaded with the embedded material; Step 4, placing the zein-chitosan-sodium polyphosphate nanoparticle solution of the embedding material obtained in step 3 in a negative pressure rotary evaporator to remove excess ethanol, adjusting the pH value, and obtaining intestinal enzyme-responsive zein-based nanoparticles with high mucus penetration and cell absorption.

2. The preparation method according to claim 1, characterized in that The embedded material is curcumin.

3. The preparation method according to claim 1, characterized in that: In the step 1, the mass ratio of zein powder to the embedding material is 9:1 to 11:

1.

4. The preparation method according to claim 1, characterized in that: In the step 1, the molecular weight of chitosan is 400-600 kDa, and chitosan is dissolved in an acetic acid aqueous solution at 80-90° C. in a water bath.

5. The preparation method according to claim 1, characterized in that: In the step 2, the mass ratio of chitosan to zein powder is 5.5:1 to 6.5:

1.

6. The preparation method according to claim 1, characterized in that: The dropping speed in step 2 is 2 to 4 drops / second.

7. The preparation method according to claim 1, characterized in that: In step 3, the mass ratio of chitosan to sodium polyphosphate is 1:0.2 to 1:4.

0.

8. The preparation method according to claim 1, characterized in that: In step 3, the concentration of zein is 0.5-1.0 mg / mL, the concentration of chitosan is 0.1-0.2 mg / mL, and the concentration of sodium polyphosphate is 0.02-0.3 mg / mL.

9. The preparation method according to claim 1, characterized in that: In step 4, the temperature of the negative pressure rotary evaporator is 40 to 50° C., and the pressure is -0.1 to -0.2 MPa; and the pH value is adjusted to 3.5 to 4.

0. 10 . Intestinal enzyme-responsive zein-based nanoparticles with high mucus permeability and cell absorption obtained by the preparation method according to any one of claims 1 to 9 .

Citation Information

Cited By

  • Preparation method of L-tryptophan compound preparation and application of L-tryptophan compound preparation in livestock feed

    CN120531058A